Association of CYP3A4 genotype with detection of Vy/JB trans-rearrangements in the peripheral blood leukocytes of pediatric cancer patients undergoing chemotherapy for all
Leuk. res
; 28(12): 1281-1286, 2004.
Artículo
en Inglés
| Coleciona SUS
| ID: biblio-945269
Biblioteca responsable:
BR440.1
Ubicación: BR440.1
ABSTRACT
Cancer patients receiving chemotherapy are exposed to high doses of cytotoxic and genotoxic drugs which, in some cases, can lead to treatment related leukemia. Since this only occurs in a minority of patients, however, it is possible some individuals are predisposed due to genetic polymorphisms in genes for enzymes that mediate drug metabolism. To address this possibility we measured the genotoxicity of chemotherapeutic agents in patients receiving treatment for ALL by the frequency of the Vã/Jâ trans-rearrangement in their peripheral blood leukocytes and compared this with CYP3A4 genotype. CYP3A4 is the most abundant of the cytochrome P450 (CYP) enzyme in the liver and intestine which contains a common −392A>G substitution in the promoter region (CYP3A4*1B allele). We found a significant increase in the frequency of rearrangements during chemotherapy only in patients homozygous for the wild type CYP3A4*1A allele. This provides a direct link between CYP3A4 genotype and susceptibility to drug genotoxicity thus strengthening the possibility that predisposition to treatment related leukemia may be measurable by simple genetic testing.
Texto completo:
Disponible
Colección:
Bases de datos nacionales
/
Brasil
Base de datos:
Coleciona SUS
Asunto principal:
Quimioterapia
/
Genotipo
/
Leucocitos
/
Neoplasias
Tipo de estudio:
Estudio diagnóstico
/
Factores de riesgo
Límite:
Niño
/
Humanos
Idioma:
Inglés
Revista:
Leuk. res
Año:
2004
Tipo del documento:
Artículo